国家自然科学基金重大项目(30330560),国家自然科学基金项目(30300175, 30400238, 30400528)和湖南省自然科学基金项目(05JJ300063).
This work was supported by grants from Key Program of The National Natural Science Foundation of China (30330560), The National Natural Science Foundation of China (30300175, 30400238, 30400528) and Natural Science Foundation of Hunan Province (05JJ300063).
BRD7基因是采用cDNA代表性差异分析法克隆得到的一个新的Bromodomain基因(GenBank 登录号AF152604). 它在鼻咽癌细胞和组织中表达明显下调,过表达BRD7基因能部分逆转鼻咽癌细胞的恶性表型. 为了揭示BRD7基因在鼻咽癌细胞和组织中表达下调的分子机制,利用生物信息学技术已预测出其启动子区. 荧光素酶活性检测结果表明该区域具有强启动子活性;转录因子Sp1特异性地结合于BRD7该启动子区;Sp1特异性阻断剂mithramycin A能明显地抑制BRD7启动子的活性和BRD7基因的表达.
BRD7, a novel bromodomain gene, has been cloned by cDNA RDA (cDNA Representational Difference Analysis). The GenBank accession number is AF152604. Previous studies showed that BRD7 gene was down-regulated in nasopharyngeal carcinoma (NPC) cells and tissues. Over expression of BRD7 in NPC cells can inhibit cell proliferation and cell cycle progression from G1 to S phase, and can partly inhibit the aberrant growth of NPC cells. In order to explore the molecular mechanisms that involved in the down-regulation of BRD7 gene in NPC cells, bioinformatic approaches were adopted and a putative promoter region was found. The luciferase expression vectors containing BRD7 promoter region were further constructed . Transient transfection results suggested that the analyzed sequence contained BRD7 promoter. Transcriptional factor Sp1 is responsive to this region. Inhibition of the Sp1 binding to BRD7 promoter by mithramycin A significantly reduced the promoter activity and the endogenous expression of BRD7 in mRNA level.
刘华英,罗晓敏,牛朝霞,彭聪,李桂源,周鸣,周艳宏,李小玲,李伟松,向波. BRD7基因调控区的克隆与功能研究[J].生物化学与生物物理进展,2006,33(6):531-539
复制生物化学与生物物理进展 ® 2025 版权所有 ICP:京ICP备05023138号-1 京公网安备 11010502031771号